These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15043978)

  • 1. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Janecka IP
    Lancet; 2004 Mar; 363(9413):993-4. PubMed ID: 15043978
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Vaupel P; Mayer A
    Lancet; 2004 Mar; 363(9413):992; author reply 993. PubMed ID: 15043976
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Gemici C
    Lancet; 2004 Mar; 363(9413):992-3; author reply 993. PubMed ID: 15043975
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Leyland-Jones B; Mahmud S
    Lancet; 2004 Jan; 363(9402):80; author reply 81-2. PubMed ID: 14724010
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Blumberg N; Heal JM
    Lancet; 2004 Jan; 363(9402):80-1; author reply 81-2. PubMed ID: 14724011
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Freidlin B; Korn EL
    Lancet; 2004 Jan; 363(9402):81; author reply 81-2. PubMed ID: 14724012
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Haddad R; Posner M
    Lancet; 2004 Jan; 363(9402):79-80; author reply 81-2. PubMed ID: 14724009
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Kaanders JH; van der Kogel AJ
    Lancet; 2004 Jan; 363(9402):78-9; author reply 81-2. PubMed ID: 14724007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comment on the article by M. Henke: "Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double blind, placebo controlled trial" or how a cytokine remains a cytokine].
    Lartigau E; Denis F
    Cancer Radiother; 2004 Jun; 8(3):131-3. PubMed ID: 15217580
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Powles T; Shamash J; Liu W
    Lancet; 2004 Jan; 363(9402):82. PubMed ID: 14724015
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lung cancer related anemia: prognosis factor, predictive, both or none?].
    Alberola V
    Med Clin (Barc); 2008 Nov; 131(16):612-3. PubMed ID: 19080852
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin and radiotherapy: a dangerous combination?
    Dunst J
    Strahlenther Onkol; 2004 Mar; 180(3):133-5. PubMed ID: 15032246
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
    Henke M; Laszig R; Rübe C; Schäfer U; Haase KD; Schilcher B; Mose S; Beer KT; Burger U; Dougherty C; Frommhold H
    Lancet; 2003 Oct; 362(9392):1255-60. PubMed ID: 14575968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin and anemia: when quality of life and survival clash].
    Fayette J
    Bull Cancer; 2003 Dec; 90(12):1033. PubMed ID: 14715420
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
    Rades D
    Oral Oncol; 2009 Feb; 45(2):91-3. PubMed ID: 18490191
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience.
    Frommhold H; Guttenberger R; Henke M
    Strahlenther Onkol; 1998 Dec; 174 Suppl 4():31-4. PubMed ID: 9879345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversial effect of epoetin in cancer: grounds for a translational research exercise?
    Apolone G
    Eur J Cancer; 2004 Jun; 40(9):1289-91. PubMed ID: 15177486
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia correction in malignancy management: threat or opportunity?
    De Los Santos JF; Thomas GM
    Gynecol Oncol; 2007 May; 105(2):517-29. PubMed ID: 17367848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.